James Costello
Concepts (405)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Bladder Neoplasms | 11 | 2023 | 211 | 2.400 |
Why?
| Gene Expression Profiling | 9 | 2023 | 1597 | 1.470 |
Why?
| Algorithms | 13 | 2018 | 1541 | 1.360 |
Why?
| Antineoplastic Agents | 7 | 2020 | 1974 | 1.030 |
Why?
| Gene Regulatory Networks | 6 | 2023 | 239 | 0.960 |
Why?
| Biomarkers, Tumor | 5 | 2022 | 1059 | 0.960 |
Why?
| Transcriptome | 7 | 2023 | 756 | 0.960 |
Why?
| Computational Biology | 9 | 2018 | 588 | 0.960 |
Why?
| Cell Line, Tumor | 18 | 2023 | 2851 | 0.890 |
Why?
| Drug Resistance, Neoplasm | 6 | 2021 | 671 | 0.870 |
Why?
| Neoplasms | 8 | 2020 | 2179 | 0.850 |
Why?
| Prostatic Neoplasms | 4 | 2023 | 940 | 0.850 |
Why?
| Crowdsourcing | 5 | 2023 | 17 | 0.830 |
Why?
| Computer Simulation | 5 | 2018 | 922 | 0.810 |
Why?
| Premature Birth | 2 | 2023 | 284 | 0.800 |
Why?
| Cell-Free Nucleic Acids | 1 | 2021 | 28 | 0.780 |
Why?
| Cisplatin | 2 | 2018 | 271 | 0.730 |
Why?
| Blood Proteins | 1 | 2021 | 248 | 0.690 |
Why?
| MutS Homolog 2 Protein | 1 | 2018 | 14 | 0.680 |
Why?
| Gene Expression Regulation, Neoplastic | 12 | 2023 | 1167 | 0.670 |
Why?
| Pre-Eclampsia | 1 | 2021 | 183 | 0.670 |
Why?
| Chromosomes, Human | 1 | 2018 | 41 | 0.660 |
Why?
| Pharmaceutical Preparations | 1 | 2020 | 167 | 0.650 |
Why?
| Gestational Age | 1 | 2021 | 765 | 0.650 |
Why?
| Whole Genome Sequencing | 1 | 2018 | 113 | 0.640 |
Why?
| Fluorescence | 1 | 2018 | 159 | 0.640 |
Why?
| CRISPR-Cas Systems | 1 | 2018 | 85 | 0.630 |
Why?
| Tripartite Motif Proteins | 1 | 2017 | 31 | 0.620 |
Why?
| Transcription Factors | 4 | 2022 | 1570 | 0.620 |
Why?
| Metabolic Networks and Pathways | 1 | 2018 | 176 | 0.600 |
Why?
| Models, Biological | 4 | 2018 | 1715 | 0.600 |
Why?
| Genetic Loci | 1 | 2018 | 281 | 0.590 |
Why?
| Breast Neoplasms | 5 | 2021 | 1965 | 0.580 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 1390 | 0.580 |
Why?
| Homeodomain Proteins | 5 | 2023 | 468 | 0.570 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2017 | 148 | 0.570 |
Why?
| Genomics | 6 | 2023 | 706 | 0.520 |
Why?
| Telomerase | 4 | 2020 | 207 | 0.510 |
Why?
| MAP Kinase Kinase Kinases | 3 | 2021 | 71 | 0.490 |
Why?
| Image Processing, Computer-Assisted | 1 | 2018 | 709 | 0.480 |
Why?
| Competitive Behavior | 1 | 2013 | 40 | 0.450 |
Why?
| DNA-Binding Proteins | 6 | 2022 | 1346 | 0.430 |
Why?
| Oligonucleotide Array Sequence Analysis | 7 | 2016 | 770 | 0.420 |
Why?
| Receptors, Androgen | 3 | 2021 | 134 | 0.420 |
Why?
| Carcinoma, Transitional Cell | 3 | 2017 | 58 | 0.400 |
Why?
| Cooperative Behavior | 2 | 2016 | 408 | 0.400 |
Why?
| Humans | 55 | 2023 | 118969 | 0.390 |
Why?
| Biomedical Research | 2 | 2016 | 612 | 0.380 |
Why?
| Rhabdomyosarcoma | 2 | 2022 | 57 | 0.380 |
Why?
| Drosophila | 3 | 2008 | 140 | 0.380 |
Why?
| Carcinoma, Pancreatic Ductal | 2 | 2023 | 210 | 0.360 |
Why?
| Lung Neoplasms | 3 | 2018 | 2220 | 0.350 |
Why?
| Mutation | 7 | 2023 | 3457 | 0.350 |
Why?
| Zebrafish Proteins | 2 | 2022 | 252 | 0.350 |
Why?
| Protein Interaction Mapping | 1 | 2009 | 104 | 0.340 |
Why?
| Protein Tyrosine Phosphatases | 2 | 2020 | 145 | 0.320 |
Why?
| Drosophila melanogaster | 1 | 2009 | 200 | 0.310 |
Why?
| DNA Helicases | 2 | 2021 | 131 | 0.300 |
Why?
| Databases, Genetic | 3 | 2018 | 253 | 0.300 |
Why?
| Prostatic Neoplasms, Castration-Resistant | 2 | 2017 | 41 | 0.290 |
Why?
| Triple Negative Breast Neoplasms | 2 | 2019 | 164 | 0.280 |
Why?
| Neoplasm Metastasis | 5 | 2020 | 544 | 0.270 |
Why?
| Pancreatic Neoplasms | 2 | 2023 | 734 | 0.260 |
Why?
| Epigenesis, Genetic | 3 | 2020 | 539 | 0.260 |
Why?
| Promoter Regions, Genetic | 6 | 2021 | 1158 | 0.260 |
Why?
| Oncogene Proteins, Fusion | 3 | 2023 | 181 | 0.260 |
Why?
| Animals | 27 | 2023 | 33381 | 0.260 |
Why?
| Meta-Analysis as Topic | 2 | 2023 | 164 | 0.250 |
Why?
| Epithelial-Mesenchymal Transition | 3 | 2021 | 176 | 0.250 |
Why?
| Proteomics | 3 | 2021 | 876 | 0.230 |
Why?
| Nuclear Proteins | 2 | 2020 | 597 | 0.220 |
Why?
| Datasets as Topic | 1 | 2023 | 103 | 0.220 |
Why?
| Sarcoma, Ewing | 1 | 2023 | 65 | 0.220 |
Why?
| MDS1 and EVI1 Complex Locus Protein | 1 | 2022 | 6 | 0.210 |
Why?
| Mice | 17 | 2023 | 15520 | 0.210 |
Why?
| Melanoma | 2 | 2023 | 664 | 0.210 |
Why?
| Neoplasm Invasiveness | 3 | 2018 | 462 | 0.210 |
Why?
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2021 | 6 | 0.210 |
Why?
| ROC Curve | 2 | 2021 | 473 | 0.210 |
Why?
| Muscle Development | 1 | 2022 | 102 | 0.200 |
Why?
| Cell Proliferation | 8 | 2021 | 2275 | 0.200 |
Why?
| Proto-Oncogene Proteins B-raf | 1 | 2023 | 202 | 0.200 |
Why?
| ADAM10 Protein | 1 | 2021 | 28 | 0.200 |
Why?
| Receptors, CCR2 | 1 | 2020 | 30 | 0.190 |
Why?
| Asymptomatic Diseases | 1 | 2021 | 81 | 0.190 |
Why?
| PAX3 Transcription Factor | 1 | 2020 | 12 | 0.190 |
Why?
| Proto-Oncogene Protein c-ets-1 | 1 | 2020 | 18 | 0.190 |
Why?
| Gene Ontology | 1 | 2020 | 55 | 0.190 |
Why?
| Forkhead Box Protein O1 | 1 | 2020 | 15 | 0.190 |
Why?
| Gamma Rays | 1 | 2021 | 52 | 0.190 |
Why?
| Carcinoma, Lobular | 1 | 2021 | 56 | 0.190 |
Why?
| Tumor Microenvironment | 2 | 2020 | 454 | 0.190 |
Why?
| Cytoreduction Surgical Procedures | 1 | 2020 | 40 | 0.190 |
Why?
| Amyloid Precursor Protein Secretases | 1 | 2021 | 76 | 0.190 |
Why?
| Wnt Signaling Pathway | 1 | 2022 | 150 | 0.190 |
Why?
| Radiosurgery | 1 | 2023 | 318 | 0.190 |
Why?
| Neoplasm Recurrence, Local | 3 | 2023 | 900 | 0.190 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 59 | 0.180 |
Why?
| CD8-Positive T-Lymphocytes | 3 | 2020 | 702 | 0.180 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2019 | 33 | 0.180 |
Why?
| Radiation Injuries | 1 | 2021 | 131 | 0.180 |
Why?
| Receptors, Interferon | 1 | 2019 | 49 | 0.180 |
Why?
| Homologous Recombination | 1 | 2019 | 22 | 0.180 |
Why?
| Small Molecule Libraries | 1 | 2020 | 80 | 0.170 |
Why?
| Discoidin Domain Receptor 2 | 1 | 2019 | 2 | 0.170 |
Why?
| Chemotherapy, Adjuvant | 1 | 2020 | 360 | 0.170 |
Why?
| Cell Differentiation | 3 | 2022 | 1753 | 0.170 |
Why?
| Trisomy | 1 | 2019 | 66 | 0.170 |
Why?
| Kynurenine | 1 | 2019 | 81 | 0.170 |
Why?
| RNA Interference | 1 | 2021 | 460 | 0.170 |
Why?
| Prognosis | 7 | 2021 | 3443 | 0.170 |
Why?
| Dasatinib | 1 | 2019 | 46 | 0.170 |
Why?
| Machine Learning | 2 | 2022 | 331 | 0.170 |
Why?
| Female | 19 | 2023 | 61564 | 0.170 |
Why?
| Reproducibility of Results | 2 | 2023 | 2874 | 0.170 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2020 | 165 | 0.160 |
Why?
| Microbiota | 2 | 2023 | 656 | 0.160 |
Why?
| SOXB1 Transcription Factors | 1 | 2019 | 61 | 0.160 |
Why?
| Fibrosis | 1 | 2021 | 483 | 0.160 |
Why?
| Mitogen-Activated Protein Kinase Kinases | 2 | 2023 | 116 | 0.160 |
Why?
| Receptors, Estrogen | 1 | 2021 | 387 | 0.160 |
Why?
| Neoadjuvant Therapy | 1 | 2020 | 333 | 0.160 |
Why?
| Molecular Conformation | 1 | 2018 | 146 | 0.160 |
Why?
| Macrolides | 1 | 2018 | 57 | 0.160 |
Why?
| Neoplasm Proteins | 2 | 2018 | 401 | 0.160 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 394 | 0.160 |
Why?
| Chloroquine | 1 | 2018 | 64 | 0.160 |
Why?
| Neoplasms, Experimental | 1 | 2019 | 158 | 0.160 |
Why?
| Monte Carlo Method | 1 | 2018 | 146 | 0.160 |
Why?
| Lysosomes | 1 | 2018 | 136 | 0.160 |
Why?
| Histone Code | 1 | 2017 | 29 | 0.160 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 404 | 0.150 |
Why?
| Signal Transduction | 6 | 2021 | 4709 | 0.150 |
Why?
| Probability | 1 | 2018 | 305 | 0.150 |
Why?
| Down Syndrome | 2 | 2019 | 356 | 0.150 |
Why?
| Cell Cycle Proteins | 1 | 2021 | 565 | 0.150 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2019 | 197 | 0.150 |
Why?
| Immunity, Cellular | 1 | 2019 | 270 | 0.150 |
Why?
| Adenocarcinoma | 1 | 2023 | 812 | 0.150 |
Why?
| Cell Death | 1 | 2018 | 339 | 0.150 |
Why?
| DNA Damage | 1 | 2019 | 357 | 0.150 |
Why?
| Data Interpretation, Statistical | 2 | 2009 | 336 | 0.140 |
Why?
| Histidine Kinase | 1 | 2016 | 33 | 0.140 |
Why?
| Cadherins | 2 | 2015 | 186 | 0.140 |
Why?
| CD24 Antigen | 1 | 2016 | 21 | 0.140 |
Why?
| B7-H1 Antigen | 1 | 2018 | 144 | 0.140 |
Why?
| Sulfonamides | 1 | 2020 | 445 | 0.140 |
Why?
| YY1 Transcription Factor | 1 | 2016 | 27 | 0.140 |
Why?
| Nomograms | 1 | 2016 | 48 | 0.140 |
Why?
| DNA Methylation | 2 | 2017 | 503 | 0.140 |
Why?
| Urologic Neoplasms | 1 | 2016 | 25 | 0.140 |
Why?
| Transcriptional Activation | 1 | 2018 | 348 | 0.140 |
Why?
| Deoxycytidine | 1 | 2017 | 136 | 0.140 |
Why?
| Drug Delivery Systems | 1 | 2019 | 306 | 0.140 |
Why?
| Organizational Innovation | 2 | 2016 | 138 | 0.140 |
Why?
| Adenosine Triphosphatases | 1 | 2016 | 158 | 0.130 |
Why?
| Ovarian Neoplasms | 1 | 2020 | 420 | 0.130 |
Why?
| Genetic Heterogeneity | 1 | 2015 | 56 | 0.130 |
Why?
| Bayes Theorem | 3 | 2023 | 344 | 0.130 |
Why?
| rho Guanine Nucleotide Dissociation Inhibitor beta | 1 | 2014 | 4 | 0.130 |
Why?
| Neoplastic Stem Cells | 1 | 2019 | 336 | 0.130 |
Why?
| Telomere Homeostasis | 1 | 2015 | 24 | 0.130 |
Why?
| Survival Rate | 4 | 2021 | 1720 | 0.130 |
Why?
| Alleles | 1 | 2017 | 832 | 0.130 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 551 | 0.130 |
Why?
| Immunotherapy | 1 | 2019 | 493 | 0.130 |
Why?
| Up-Regulation | 1 | 2018 | 872 | 0.130 |
Why?
| Membrane Proteins | 1 | 2021 | 1055 | 0.120 |
Why?
| Histone Demethylases | 1 | 2014 | 28 | 0.120 |
Why?
| Transcription, Genetic | 3 | 2017 | 1323 | 0.120 |
Why?
| Ubiquitin Thiolesterase | 1 | 2014 | 38 | 0.120 |
Why?
| rho GTP-Binding Proteins | 1 | 2014 | 65 | 0.120 |
Why?
| Longitudinal Studies | 1 | 2021 | 2513 | 0.120 |
Why?
| Receptors, Antigen, T-Cell | 1 | 2018 | 632 | 0.120 |
Why?
| Ornithine Decarboxylase Inhibitors | 1 | 2013 | 7 | 0.120 |
Why?
| Phylogeny | 3 | 2023 | 816 | 0.120 |
Why?
| Microsatellite Repeats | 1 | 2014 | 143 | 0.120 |
Why?
| Anabolic Agents | 1 | 2013 | 12 | 0.120 |
Why?
| Infant, Newborn | 2 | 2023 | 5255 | 0.120 |
Why?
| High-Throughput Screening Assays | 1 | 2015 | 122 | 0.120 |
Why?
| Phenotype | 2 | 2020 | 3003 | 0.120 |
Why?
| Drug Synergism | 1 | 2014 | 339 | 0.120 |
Why?
| Arthritis, Rheumatoid | 1 | 2022 | 989 | 0.120 |
Why?
| Databases, Protein | 2 | 2014 | 60 | 0.120 |
Why?
| International Cooperation | 1 | 2014 | 177 | 0.120 |
Why?
| Organ Sparing Treatments | 1 | 2013 | 31 | 0.120 |
Why?
| Drug Combinations | 1 | 2014 | 291 | 0.120 |
Why?
| Epigenomics | 1 | 2014 | 107 | 0.120 |
Why?
| Gene Expression Regulation, Developmental | 2 | 2022 | 814 | 0.120 |
Why?
| Models, Theoretical | 1 | 2017 | 556 | 0.120 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2020 | 532 | 0.120 |
Why?
| Models, Molecular | 1 | 2018 | 1435 | 0.110 |
Why?
| Brain Neoplasms | 1 | 2021 | 1022 | 0.110 |
Why?
| Xenograft Model Antitumor Assays | 3 | 2021 | 740 | 0.110 |
Why?
| Biomarkers | 2 | 2021 | 3588 | 0.110 |
Why?
| Pregnancy | 2 | 2023 | 5691 | 0.110 |
Why?
| Cluster Analysis | 2 | 2016 | 481 | 0.110 |
Why?
| Superoxides | 1 | 2013 | 221 | 0.110 |
Why?
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 32 | 0.110 |
Why?
| Prostate | 1 | 2013 | 158 | 0.110 |
Why?
| Models, Statistical | 1 | 2016 | 636 | 0.110 |
Why?
| Integrins | 2 | 2023 | 82 | 0.110 |
Why?
| Community-Institutional Relations | 1 | 2013 | 91 | 0.110 |
Why?
| Software | 2 | 2014 | 613 | 0.110 |
Why?
| Tumor Suppressor Proteins | 1 | 2014 | 289 | 0.110 |
Why?
| Alternative Splicing | 1 | 2013 | 193 | 0.100 |
Why?
| Genome-Wide Association Study | 1 | 2018 | 1323 | 0.100 |
Why?
| B-Lymphocytes | 2 | 2014 | 770 | 0.100 |
Why?
| Apoptosis | 3 | 2021 | 2484 | 0.100 |
Why?
| Mice, Inbred C57BL | 5 | 2021 | 4908 | 0.100 |
Why?
| Genome, Insect | 2 | 2009 | 23 | 0.100 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 237 | 0.100 |
Why?
| Saccharomyces cerevisiae | 3 | 2012 | 495 | 0.100 |
Why?
| Reactive Oxygen Species | 1 | 2013 | 576 | 0.100 |
Why?
| Male | 10 | 2023 | 57800 | 0.090 |
Why?
| MCF-7 Cells | 2 | 2021 | 111 | 0.090 |
Why?
| Hematopoietic Stem Cells | 1 | 2013 | 359 | 0.090 |
Why?
| Testosterone | 1 | 2013 | 351 | 0.090 |
Why?
| Gene Expression Regulation, Bacterial | 1 | 2012 | 279 | 0.090 |
Why?
| Horns | 1 | 2009 | 1 | 0.090 |
Why?
| Expressed Sequence Tags | 1 | 2009 | 38 | 0.090 |
Why?
| Pseudogenes | 1 | 2009 | 20 | 0.090 |
Why?
| Enzyme Inhibitors | 1 | 2013 | 827 | 0.090 |
Why?
| Genetic Predisposition to Disease | 1 | 2018 | 2275 | 0.090 |
Why?
| Inflammation | 1 | 2020 | 2566 | 0.090 |
Why?
| Coleoptera | 1 | 2009 | 27 | 0.090 |
Why?
| Systems Integration | 1 | 2009 | 42 | 0.090 |
Why?
| Drug Discovery | 2 | 2022 | 124 | 0.090 |
Why?
| Models, Genetic | 2 | 2009 | 595 | 0.090 |
Why?
| Genes, Fungal | 1 | 2009 | 49 | 0.090 |
Why?
| Stem Cells | 1 | 2013 | 559 | 0.080 |
Why?
| Tumor Cells, Cultured | 2 | 2021 | 874 | 0.080 |
Why?
| Genes, Insect | 1 | 2007 | 22 | 0.080 |
Why?
| Zebrafish | 2 | 2022 | 434 | 0.080 |
Why?
| Genetic Diseases, Inborn | 1 | 2008 | 46 | 0.080 |
Why?
| Gene Deletion | 1 | 2009 | 361 | 0.080 |
Why?
| BRCA1 Protein | 2 | 2020 | 57 | 0.080 |
Why?
| Mitochondria | 1 | 2013 | 786 | 0.080 |
Why?
| Combined Modality Therapy | 2 | 2020 | 1166 | 0.080 |
Why?
| Genome, Human | 1 | 2009 | 387 | 0.080 |
Why?
| Disease | 1 | 2008 | 98 | 0.070 |
Why?
| Genetics, Population | 1 | 2008 | 207 | 0.070 |
Why?
| Oxidative Stress | 1 | 2013 | 1178 | 0.070 |
Why?
| Selection, Genetic | 1 | 2008 | 252 | 0.070 |
Why?
| Prednisone | 2 | 2017 | 235 | 0.070 |
Why?
| Chromatin | 2 | 2022 | 441 | 0.070 |
Why?
| T-Lymphocytes | 1 | 2013 | 1774 | 0.070 |
Why?
| Follow-Up Studies | 3 | 2020 | 4596 | 0.070 |
Why?
| Cell Line | 3 | 2019 | 2707 | 0.060 |
Why?
| Adult | 3 | 2021 | 31510 | 0.060 |
Why?
| Base Sequence | 3 | 2017 | 2159 | 0.060 |
Why?
| Anti-Bacterial Agents | 1 | 2013 | 1510 | 0.060 |
Why?
| Cell Movement | 2 | 2021 | 896 | 0.060 |
Why?
| Proto-Oncogene Protein c-fli-1 | 1 | 2023 | 16 | 0.060 |
Why?
| Evolution, Molecular | 1 | 2007 | 454 | 0.060 |
Why?
| RNA-Binding Protein EWS | 1 | 2023 | 16 | 0.060 |
Why?
| BCG Vaccine | 1 | 2023 | 25 | 0.060 |
Why?
| Protein Binding | 2 | 2020 | 1975 | 0.060 |
Why?
| Internet | 1 | 2008 | 633 | 0.060 |
Why?
| Cells, Cultured | 3 | 2016 | 4077 | 0.060 |
Why?
| Mice, Nude | 2 | 2016 | 663 | 0.050 |
Why?
| Biological Assay | 1 | 2023 | 122 | 0.050 |
Why?
| Myogenin | 1 | 2022 | 13 | 0.050 |
Why?
| Vagina | 1 | 2023 | 148 | 0.050 |
Why?
| MyoD Protein | 1 | 2022 | 28 | 0.050 |
Why?
| Rhabdomyosarcoma, Embryonal | 1 | 2022 | 17 | 0.050 |
Why?
| Proteins | 1 | 2008 | 938 | 0.050 |
Why?
| Adjuvants, Immunologic | 1 | 2023 | 207 | 0.050 |
Why?
| Regulatory Sequences, Nucleic Acid | 1 | 2022 | 80 | 0.050 |
Why?
| Cell Lineage | 2 | 2013 | 318 | 0.050 |
Why?
| Mice, Knockout | 2 | 2022 | 2680 | 0.050 |
Why?
| Chondrogenesis | 1 | 2022 | 79 | 0.050 |
Why?
| Aged | 4 | 2023 | 19656 | 0.050 |
Why?
| Phenylthiohydantoin | 1 | 2021 | 40 | 0.050 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2022 | 93 | 0.050 |
Why?
| Neural Crest | 1 | 2022 | 117 | 0.050 |
Why?
| Skull | 1 | 2022 | 127 | 0.050 |
Why?
| Wnt Proteins | 1 | 2022 | 140 | 0.050 |
Why?
| Ephrin-B2 | 1 | 2021 | 42 | 0.050 |
Why?
| Breast | 1 | 2021 | 140 | 0.050 |
Why?
| Nitriles | 1 | 2021 | 155 | 0.050 |
Why?
| Benzamides | 1 | 2021 | 176 | 0.050 |
Why?
| Cartilage | 1 | 2022 | 183 | 0.050 |
Why?
| Tamoxifen | 1 | 2021 | 198 | 0.050 |
Why?
| Quinolinic Acid | 1 | 2019 | 6 | 0.050 |
Why?
| beta Catenin | 1 | 2022 | 219 | 0.050 |
Why?
| Biosynthetic Pathways | 1 | 2019 | 19 | 0.040 |
Why?
| Chromatin Immunoprecipitation | 1 | 2020 | 136 | 0.040 |
Why?
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 44 | 0.040 |
Why?
| Androgens | 1 | 2021 | 167 | 0.040 |
Why?
| Chondrocytes | 1 | 2022 | 206 | 0.040 |
Why?
| Melanoma, Experimental | 1 | 2020 | 118 | 0.040 |
Why?
| Enhancer Elements, Genetic | 1 | 2020 | 152 | 0.040 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 160 | 0.040 |
Why?
| Double-Blind Method | 1 | 2023 | 1687 | 0.040 |
Why?
| Nanog Homeobox Protein | 1 | 2019 | 11 | 0.040 |
Why?
| Inhibitor of Differentiation Proteins | 1 | 2018 | 4 | 0.040 |
Why?
| Cell Cycle | 1 | 2021 | 550 | 0.040 |
Why?
| Mice, SCID | 1 | 2019 | 333 | 0.040 |
Why?
| 5-Methylcytosine | 1 | 2017 | 16 | 0.040 |
Why?
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 38 | 0.040 |
Why?
| Kaplan-Meier Estimate | 1 | 2020 | 842 | 0.040 |
Why?
| Sequence Analysis, RNA | 1 | 2020 | 409 | 0.040 |
Why?
| CpG Islands | 1 | 2017 | 119 | 0.040 |
Why?
| Protein Kinase Inhibitors | 1 | 2023 | 811 | 0.040 |
Why?
| Mice, Inbred NOD | 1 | 2019 | 574 | 0.040 |
Why?
| Polycomb Repressive Complex 2 | 1 | 2017 | 60 | 0.040 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 2016 | 43 | 0.040 |
Why?
| Co-Repressor Proteins | 1 | 2016 | 17 | 0.040 |
Why?
| Taxoids | 1 | 2016 | 98 | 0.040 |
Why?
| Chromosome Deletion | 1 | 2016 | 95 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2016 | 161 | 0.030 |
Why?
| Mice, Inbred BALB C | 1 | 2019 | 1206 | 0.030 |
Why?
| Logistic Models | 1 | 2021 | 1901 | 0.030 |
Why?
| Heterografts | 1 | 2016 | 130 | 0.030 |
Why?
| Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 245 | 0.030 |
Why?
| Protein Domains | 1 | 2016 | 212 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2016 | 167 | 0.030 |
Why?
| Gene Knockdown Techniques | 1 | 2016 | 311 | 0.030 |
Why?
| rhoC GTP-Binding Protein | 1 | 2014 | 5 | 0.030 |
Why?
| Interdisciplinary Communication | 1 | 2016 | 191 | 0.030 |
Why?
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2014 | 5 | 0.030 |
Why?
| Exome | 1 | 2016 | 220 | 0.030 |
Why?
| Chromosome Mapping | 1 | 2016 | 510 | 0.030 |
Why?
| Sequence Analysis, DNA | 2 | 2008 | 755 | 0.030 |
Why?
| Urothelium | 1 | 2015 | 33 | 0.030 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2016 | 2062 | 0.030 |
Why?
| rac1 GTP-Binding Protein | 1 | 2014 | 58 | 0.030 |
Why?
| Metabolomics | 1 | 2019 | 550 | 0.030 |
Why?
| CD4-Positive T-Lymphocytes | 1 | 2020 | 984 | 0.030 |
Why?
| Survival Analysis | 1 | 2017 | 1267 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2014 | 245 | 0.030 |
Why?
| Intrinsically Disordered Proteins | 1 | 2014 | 15 | 0.030 |
Why?
| Sequence Analysis, Protein | 1 | 2014 | 31 | 0.030 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 341 | 0.030 |
Why?
| Neoplasm Grading | 1 | 2015 | 258 | 0.030 |
Why?
| Gene Expression | 1 | 2019 | 1489 | 0.030 |
Why?
| Eflornithine | 1 | 2013 | 8 | 0.030 |
Why?
| Ornithine Decarboxylase | 1 | 2013 | 12 | 0.030 |
Why?
| Follistatin | 1 | 2013 | 12 | 0.030 |
Why?
| Molecular Sequence Data | 2 | 2009 | 2871 | 0.030 |
Why?
| Point Mutation | 1 | 2015 | 228 | 0.030 |
Why?
| Gene Expression Regulation | 1 | 2023 | 2445 | 0.030 |
Why?
| Amino Acid Motifs | 1 | 2014 | 200 | 0.030 |
Why?
| Aminoglycosides | 1 | 2013 | 15 | 0.030 |
Why?
| Protein Conformation | 1 | 2016 | 848 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2016 | 369 | 0.030 |
Why?
| Blotting, Western | 1 | 2016 | 1194 | 0.030 |
Why?
| Area Under Curve | 1 | 2014 | 296 | 0.030 |
Why?
| beta-Lactams | 1 | 2013 | 28 | 0.030 |
Why?
| Polymerase Chain Reaction | 1 | 2016 | 1012 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 453 | 0.030 |
Why?
| Databases, Factual | 1 | 2018 | 1231 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2016 | 1223 | 0.030 |
Why?
| Clinical Trials as Topic | 1 | 2017 | 968 | 0.030 |
Why?
| Treatment Outcome | 2 | 2017 | 9342 | 0.030 |
Why?
| Enzyme Activation | 1 | 2015 | 828 | 0.030 |
Why?
| Organ Size | 1 | 2013 | 460 | 0.030 |
Why?
| Doxycycline | 1 | 2012 | 60 | 0.030 |
Why?
| Genes, ras | 1 | 2012 | 95 | 0.030 |
Why?
| Cell Cycle Checkpoints | 1 | 2012 | 87 | 0.030 |
Why?
| Bone Marrow Transplantation | 1 | 2013 | 244 | 0.030 |
Why?
| Antigens, CD | 1 | 2014 | 460 | 0.030 |
Why?
| Quinolones | 1 | 2013 | 98 | 0.030 |
Why?
| Hydrogen Peroxide | 1 | 2013 | 305 | 0.030 |
Why?
| Young Adult | 2 | 2017 | 10793 | 0.030 |
Why?
| Cytokines | 1 | 2019 | 1900 | 0.030 |
Why?
| Benzimidazoles | 1 | 2012 | 140 | 0.030 |
Why?
| Repressor Proteins | 1 | 2014 | 377 | 0.030 |
Why?
| Linear Models | 1 | 2014 | 827 | 0.020 |
Why?
| Middle Aged | 3 | 2017 | 27617 | 0.020 |
Why?
| Adenosine Triphosphate | 1 | 2013 | 439 | 0.020 |
Why?
| DNA | 1 | 2017 | 1388 | 0.020 |
Why?
| Recombinant Proteins | 1 | 2013 | 1308 | 0.020 |
Why?
| Pupa | 1 | 2009 | 10 | 0.020 |
Why?
| Gene Library | 1 | 2009 | 127 | 0.020 |
Why?
| Body Weight | 1 | 2013 | 934 | 0.020 |
Why?
| Cell Survival | 1 | 2012 | 1047 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2013 | 1691 | 0.020 |
Why?
| Larva | 1 | 2009 | 213 | 0.020 |
Why?
| Adolescent | 2 | 2017 | 18479 | 0.020 |
Why?
| Staphylococcus aureus | 1 | 2012 | 394 | 0.020 |
Why?
| Mice, Transgenic | 1 | 2013 | 2025 | 0.020 |
Why?
| Escherichia coli | 1 | 2012 | 758 | 0.020 |
Why?
| Synteny | 1 | 2007 | 17 | 0.020 |
Why?
| Gene Order | 1 | 2007 | 28 | 0.020 |
Why?
| Disease Progression | 1 | 2015 | 2490 | 0.020 |
Why?
| Genome, Mitochondrial | 1 | 2007 | 26 | 0.020 |
Why?
| Codon | 1 | 2007 | 89 | 0.020 |
Why?
| Risk Factors | 1 | 2021 | 8999 | 0.020 |
Why?
| RNA, Messenger | 1 | 2015 | 2657 | 0.020 |
Why?
| DNA Transposable Elements | 1 | 2007 | 102 | 0.020 |
Why?
| Sequence Alignment | 1 | 2007 | 336 | 0.020 |
Why?
| Immunity | 1 | 2007 | 129 | 0.020 |
Why?
| Multigene Family | 1 | 2007 | 200 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 6412 | 0.020 |
Why?
| Terminology as Topic | 1 | 2008 | 211 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6561 | 0.020 |
Why?
| RNA, Untranslated | 1 | 2007 | 115 | 0.020 |
Why?
| Reproduction | 1 | 2007 | 189 | 0.020 |
Why?
| Drosophila Proteins | 1 | 2007 | 171 | 0.020 |
Why?
| Muscle, Skeletal | 1 | 2013 | 1515 | 0.020 |
Why?
| Child | 1 | 2023 | 19129 | 0.010 |
Why?
| RNA | 1 | 2008 | 833 | 0.010 |
Why?
| Disease Models, Animal | 1 | 2008 | 3730 | 0.010 |
Why?
|
|
Costello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|